Anticoagulant heparan sulfate to not clot--or not? (Q37784309)

23 August 2017

title

Anticoagulant heparan sulfate to not clot--or not? (English)

1 reference

23 August 2017

1 reference

1 reference

Nicholas W Shworak

1

1 reference

23 August 2017

Takashi Kobayashi

series ordinal

2

1 reference

23 August 2017

Ariane de Agostini

series ordinal

3

1 reference

23 August 2017

Nicole C Smits

series ordinal

4

1 reference

23 August 2017

publication date

1 January 2010

1 reference

Progress in Molecular Biology and Translational Science

23 August 2017

published in

1 reference

23 August 2017

volume

93

1 reference

23 August 2017

page(s)

153-178

1 reference

Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Anticoagulant Action of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Inherited Antithrombin Deficiency Causing Thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Molecular Heterogeneity of Inherited Antithrombin III Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The separation of active and inactive forms of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Allosteric activation of antithrombin critically depends upon hinge region extension

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Correlation between structure and function of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: a potent system of proteolysis control

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Mice deficient in heparan sulfate 3-O-sulfotransferase-1: Normal hemostasis with unexpected perinatal phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

A murine model of myocardial microvascular thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Heparan sulphate with no affinity for antithrombin III and the control of haemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

A model for the stoichiometric regulation of blood coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

1 reference

7 January 2021

Platelet procoagulant complex assembly in a tissue factor-initiated system

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Complete antithrombin deficiency in mice results in embryonic lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor Pool

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Expression of N-deacetylase/sulfotransferase and 3-O-sulfotransferase in rat alveolar type II cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Serpins in prokaryotes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Regulation of Notch signaling by Drosophila heparan sulfate 3-O sulfotransferase.

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Treatment of porcine sepsis with high-dose antithrombin III reduces tissue edema and effusion but does not increase risk for bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1 alpha in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Syndecan-4 as antithrombin receptor of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The glycosaminoglycans of the human artery and their changes in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

Characterization of a Heparan Sulfate 3-O-Sulfotransferase-5, an Enzyme Synthesizing a Tetrasulfated Disaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

The anti-inflammatory actions of antithrombin--a review

1 reference

https://api.crossref.org/works/10.1016%2FS1877-1173%2810%2993008-1

7 January 2021

10.1016/S1877-1173(10)93008-1

Identifiers

DOI

1 reference

release_7fj3rlbgjnhipkbup3kbc3yma4

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7fj3rlbgjnhipkbup3kbc3yma4

24 November 2022

mapped directly with Wikidata item

1 reference